“…However, other cytokines, such as EGF and TGF-a, which were not examined in the present study, may be involved to a small extent because the stimulation of keratinocyte proliferation was not completely inhibited by anti-IL-6 MoAb, even at concentrations as high as 50 mg mL 21 . 9,14,30 From these results, we conclude that DBcAMP stimulates epithelialization with keratinocytes through an increase in IL-6 production by fibroblasts, and that it also transiently enhances the production of TGF-b1 by fibroblasts at an early stage of incubation. This series of actions on the stimulation of production of cytokines, together with the enhancement of cell migration, 18 are thought to be the mechanisms of action of DBcAMP in clinically stimulating the healing of skin ulcers, particularly chronic wounds, 7,31 such as decubitus ulcers.…”